The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and ...
Regeneron Pharmaceuticals Inc. will offer a gene therapy that restored hearing for a small number of profoundly deaf children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results